Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 13
2003 27
2004 16
2005 21
2006 15
2007 16
2008 17
2009 25
2010 22
2011 30
2012 28
2013 30
2014 27
2015 25
2016 42
2017 38
2018 33
2019 34
2020 34
2021 43
2022 27
2023 18
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

496 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studies.
Kobayashi T, Matsuoka K, Watanabe M, Hisamatsu T, Hirai F, Milata J, Li X, Morris N, Arora V, Ishizuka T, Matsuo K, Satoi Y, Milch C, Hibi T. Kobayashi T, et al. Among authors: watanabe m. Intest Res. 2024 Apr;22(2):172-185. doi: 10.5217/ir.2023.00043. Epub 2024 Apr 25. Intest Res. 2024. PMID: 38720466 Free PMC article.
Identification and epidemiological study of an uncultured flavivirus from ticks using viral metagenomics and pseudoinfectious viral particles.
Kobayashi D, Inoue Y, Suzuki R, Matsuda M, Shimoda H, Faizah AN, Kaku Y, Ishijima K, Kuroda Y, Tatemoto K, Virhuez-Mendoza M, Harada M, Nishino A, Inumaru M, Yonemitsu K, Kuwata R, Takano A, Watanabe M, Higa Y, Sawabe K, Maeda K, Isawa H. Kobayashi D, et al. Among authors: watanabe m. Proc Natl Acad Sci U S A. 2024 May 7;121(19):e2319400121. doi: 10.1073/pnas.2319400121. Epub 2024 Apr 30. Proc Natl Acad Sci U S A. 2024. PMID: 38687787
Discovery of non-genomic drivers of YAP signaling modulating the cell plasticity in CRC tumor lines.
Ogasawara N, Kano Y, Yoneyama Y, Kobayashi S, Watanabe S, Kirino S, Velez-Bravo FD, Hong Y, Ostapiuk A, Lutsik P, Onishi I, Yamauchi S, Hiraguri Y, Ito G, Kinugasa Y, Ohashi K, Watanabe M, Okamoto R, Tejpar S, Yui S. Ogasawara N, et al. Among authors: watanabe m. iScience. 2024 Feb 16;27(3):109247. doi: 10.1016/j.isci.2024.109247. eCollection 2024 Mar 15. iScience. 2024. PMID: 38439969 Free PMC article.
Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBD.
Vieujean S, Lindsay JO, D'Amico F, Ahuja V, Silverberg MS, Sood A, Yamamoto-Furusho JK, Nagahori M, Watanabe M, Koutroubakis IE, Foteinogiannopoulou K, Avni Biron I, Walsh A, Outtier A, Nordestgaard RLM, Abreu MT, Dubinsky M, Siegel C, Louis E, Dotan I, Reinisch W, Danese S, Rubin DT, Peyrin-Biroulet L. Vieujean S, et al. Among authors: watanabe m. J Crohns Colitis. 2024 Apr 23;18(4):548-559. doi: 10.1093/ecco-jcc/jjad180. J Crohns Colitis. 2024. PMID: 37864829
Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE.
Schreiber S, Rogler G, Watanabe M, Vermeire S, Maaser C, Danese S, Faes M, Van Hoek P, Hsieh J, Moerch U, Zhou Y, de Haas A, Rudolph C, Oortwijn A, Loftus EV Jr. Schreiber S, et al. Among authors: watanabe m. Aliment Pharmacol Ther. 2023 Nov;58(9):874-887. doi: 10.1111/apt.17674. Epub 2023 Sep 18. Aliment Pharmacol Ther. 2023. PMID: 37718932 Clinical Trial.
Real-World Safety and Efficacy of Biosimilar CT-P13 in Patients with Immune-Mediated Inflammatory Diseases: Integrated Analysis of Three Japanese Prospective Observational Studies.
Takeuchi T, Nishikawa K, Yamada F, Morita A, Ohtsuki M, Suzuki Y, Watanabe M, Yamanaka H, Hibi T. Takeuchi T, et al. Among authors: watanabe m. Drug Saf. 2023 Oct;46(10):991-1005. doi: 10.1007/s40264-023-01340-1. Epub 2023 Sep 12. Drug Saf. 2023. PMID: 37700154 Free PMC article.
Clinical Effect of the C-Reactive Protein to Serum Albumin Ratio in Patients with Metastatic Gastric or Gastroesophageal Junction Cancer Treated with Trifluridine/Tipiracil.
Hashimoto I, Kano K, Onuma S, Suematsu H, Nagasawa S, Kanematsu K, Furusawa K, Hamaguchi T, Watanabe M, Hayashi K, Furuta M, Inokuchi Y, Machida N, Aoyama T, Yamada T, Rino Y, Ogata T, Oshima T. Hashimoto I, et al. Among authors: watanabe m. J Pers Med. 2023 May 31;13(6):923. doi: 10.3390/jpm13060923. J Pers Med. 2023. PMID: 37373912 Free PMC article.
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study.
Matsuoka K, Yamazaki H, Nagahori M, Kobayashi T, Omori T, Mikami Y, Fujii T, Shinzaki S, Saruta M, Matsuura M, Yamamoto T, Motoya S, Hibi T, Watanabe M, Fernandez J, Fukuhara S, Hisamatsu T. Matsuoka K, et al. Among authors: watanabe m. J Gastroenterol. 2023 Aug;58(8):751-765. doi: 10.1007/s00535-023-02005-7. Epub 2023 Jun 23. J Gastroenterol. 2023. PMID: 37351647 Free PMC article.
Evaluation of Irinotecan and Trifluridine/Tipiracil as Fourth-line Treatments After Third-line Nivolumab for Advanced Gastric Cancer.
Hayashi K, Furuta M, Furusawa K, Hamaguchi T, Watanabe M, Inokuchi Y, Onuma S, Hashimoto I, Suematsu H, Nagasawa S, Kanematsu K, Yamada T, Notsu A, Ogata T, Oshima T, Machida N, Furuse J, Maeda S. Hayashi K, et al. Among authors: watanabe m. Anticancer Res. 2023 Jun;43(6):2831-2840. doi: 10.21873/anticanres.16452. Anticancer Res. 2023. PMID: 37247885
496 results